Fragile X syndrome (FXS) is the most common form of inherited mental retardation, with an incidence of about 1:4000 in males and 1:8000 in females. Individuals with FXS display moderate to severe mental retardation as well as craniofacial abnormalities and connective tissue dysplasia (Hagerman and Hagerman, 2002) . Fragile X mental retardation-1 (Fmr1) gene encodes an RNA-binding protein, FMRP, which is highly conserved during evolution. FMRP consists of two K-homology (KH1-2) domains and an RGG-box domain (Fig. 1A) . It also has a nuclear localization (NLS) and an export (NES) signal (Fig. 1A) . Recently, the RGG-box has been demonstrated to mediate binding to a subset of RNAs with G-quartet structure (Darnell et al., 2001) . Xenopus FMRP had 90%, 95%, 90%, 100% and 61% amino acid sequence identities to NLS, KH1, KH2, NES and RGG box domains of human FMRP, respectively (Fig. 1A) . Phylogenetic analysis further revealed that the amino acid sequences of Xenopus FMRP is closer to human FMRP than either zebrafish or Drosophila (Fig. 1B) , suggesting that it will serve as a useful model to study FMRP function(s).
Northern blot analysis of developing embryos indicated that Xenopus Fmr1 has a large maternal component, most of which disappeared prior to gastrulation (Fig. 2) . Zygotic expression of Fmr1 began at about gastrula (st. 10) and gradually increased Int. J. Dev. Biol. 49: 981-984 (2005) (Fig. 3A) . This distribution resembled the expression pattern of neural crest marker AP-2α (compare Fig. 3A and 3B). However, unlike the AP-2α expression at this stage (Luo et al., 2002) , Fmr1 transcript levels were higher in the CNS and eye (Fig. 3A , E and G).
Horizontal sections of an early tailbud stage embryo further revealed that endodermal, mesodermal and mesenchymal (neural crest) regions of the pharyngeal arches expressed Fmr1 ( Fig. 3A and D) . By early tadpole stage (st. 35), forebrain, midbrain, hindbrain regions and the notochord showed high Fmr1 expression (Fig. 3C , F and G). Similar findings in the CNS (Agulhon et al., 1999) and notochord (Hergersberg et al., 1995) have been observed in mice. Again, craniofacial regions including the ear vesicles (Fig. 3F) and eye ( Fig. 3G ) displayed high Fmr1 transcript levels at this stage. Furthermore, in the late tadpole (st. 45) CNS, the olfactory bulbs and the cerebellum displayed strong Fmr1 expression (Fig. 4) . In this paper, we demonstrated the developmental expression pattern of Fmr1 in Xenopus embryos. Although previous studies have hinted at Fmr1 expression in the neural crest cells and branchial arches in mice (Agulhon et al., 1999 , de Diego Otero, 2000 , our present data provide a clear evidence for Fmr1 expression in these regions. Because various tissue structures affected in FXS are derivatives of cranial neural crest, our findings carry important implications for understanding the FXS pathogenesis. Therefore, further examination of the role of Fmr1 expression in the pharyngeal arches as well as various craniofacial regions would undoubtedly enhance our understanding of the Fragile X pathology. Finally, since many tools are available to study various developmental processes using Xenopus development, this system should serve as an excellent animal model to investigate the role of Fmr1 expression during embryonic development.
Experimental Procedures

Protein alignment and phylogenetic analysis
The protein multiple sequence alignment was constructed with DS Gene 1.5 (Accelrys). Phylogenetic analysis was performed with DS Gene 1.5 using the Neighbor Joining Method and bootstrap analysis was performed with 1,000 resampled datasets.
Northern blot hybridization
RNAs were analyzed on Glyoxal gels (Ambion, Inc). Northern blots were washed in 0.2X SSPE at 65ºC. Fmr1 probe was labeled with 32P-dCTP by primer extension (Amersham Pharmacia). 
In situ hybridization
Whole-mount in situ hybridization was performed as described previously (Harland, 1991) using digoxygenin antisense probes for Xenopus Fmr1 and AP-2α (Luo et al., 2003) . Xenopus Fmr1 antisense probe was synthesized from pGEM72-xFmr1 plasmid (Siomi et al., 1995) containing the full-length Xenopus Fmr1 using primers: forward 5'-cgg cga tct aga CTC CAA TGG AGC TTT CTA C-3'; reverse 5'-gca taa gga gct cTC AAT TGC AGT CAC CCC AG-3' (Xba1 and Sac1 sites are underlined in the primer sequence, respectively). The PCR product was digested with Xba1 and Sac1, gel purified and subcloned into Xba1 and Sac1 sites in pBluescript SK-vector (Stratagene). It was then linearized with Xba1 and in vitro transcribed in the presence of digoxygenin and T3 polymerase 
